N
KZR

Nuveen’s Kezar Life Sciences KZR Stock Holding History

Nuveen’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,476
Closed -$284K – 3382
2024
Q1 		$284K Hold
31,476
– – ﹤0.01% 3113
2023
Q4 		$298K Buy
31,476
+119
+0.4% +$1.05K ﹤0.01% 3149
2023
Q3 		$373K Sell
31,357
-158
-0.5% -$2.8K ﹤0.01% 2927
2023
Q2 		$772K Sell
31,515
-23,619
-43% -$615K ﹤0.01% 2768
2023
Q1 		$1.73M Sell
55,134
-70,595
-56% -$4.08M ﹤0.01% 2395
2022
Q4 		$8.85M Sell
125,729
-12,001
-9% -$890K ﹤0.01% 1576
2022
Q3 		$11.9M Buy
137,730
+80,054
+139% +$7.78M ﹤0.01% 1372
2022
Q2 		$4.77M Buy
57,676
+43,424
+305% +$3.83M ﹤0.01% 1976
2022
Q1 		$2.11M Sell
14,252
-3,650
-20% -$524K ﹤0.01% 2480
2021
Q4 		$2.18M Buy
17,902
+562
+3% +$63.4K ﹤0.01% 2528
2021
Q3 		$1.69M Sell
17,340
-377
-2% -$25K ﹤0.01% 2752
2021
Q2 		$962K Buy
17,717
+215
+1% +$12.2K ﹤0.01% 3024
2021
Q1 		$1.04M Buy
17,502
+937
+6% +$54.8K ﹤0.01% 2871
2020
Q4 		$865K Sell
16,565
-109
-0.7% -$6.06K ﹤0.01% 2858
2020
Q3 		$807K Buy
16,674
+3,373
+25% +$161K ﹤0.01% 2777
2020
Q2 		$689K Buy
13,301
+2,173
+20% +$110K ﹤0.01% 2784
2020
Q1 		$486K Buy
11,128
+7,037
+172% +$286K ﹤0.01% 2781
2019
Q4 		$164K Sell
4,091
-2,013
-33% -$62K ﹤0.01% 3089
2019
Q3 		$200K Buy
6,104
+1,621
+36% +$78.3K ﹤0.01% 3123
2019
Q2 		$346K Buy
+4,483
New +$697K ﹤0.01% 3096

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Nuveen's KZR Position: Q2 2024 in Review

Nuveen sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 31,476 shares — an estimated $284K sold.

Nuveen first reported a position in KZR in Q2 2019 and held it in 20 quarters. The position peaked at $11.9M in Q3 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Nuveen reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 31,476 Kezar Life Sciences shares in Q2 2024, an estimated $284K.
  • Nuveen first reported a position in Kezar Life Sciences in Q2 2019 and held it in 20 quarters.
  • Nuveen's Kezar Life Sciences position peaked at $11.9M in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.